Microplastics and Osteoarthritis: An Emerging Joint Risk

Osteoarthritis is one of the leading causes of disability worldwide, and its usual suspects are familiar: aging, obesity, genetics, and mechanical wear. A 2025 translational review in the Journal of Translational Medicine adds a less obvious name to that list—the microplastics accumulating in our food, water, and air.[J Transl Med, 2025]

The claim is striking because it moves microplastics from the environmental column into the clinical one. The review reports that microplastic particles have been detected directly in human cartilage, bone, and spinal discs, and it lays out a molecular route by which those particles could feed the inflammation that degrades a joint.[J Transl Med, 2025]

It is worth being careful here. This is a synthesis of existing evidence, not a controlled trial, and the authors say so plainly. Below is what the paper actually supports, and where it stops.

Microplastics have been found inside human joints

The most concrete finding in the review is a matter of presence. Microplastics are no longer just a problem for fish and shorelines—they have been measured inside human skeletal tissue.

The paper cites detection of microplastics in human intervertebral discs at 61.1 ± 44.2 particles per gram, in cartilage at 26.4 ± 17.6 particles per gram, and in bone at 22.9 ± 15.7 particles per gram. The most prevalent polymers were polypropylene (35%), ethylene vinyl acetate copolymer (30%), and polystyrene (20%).[J Transl Med, 2025]

26.4/g

These particles are described as reaching skeletal tissue through blood circulation, with in vivo experiments showing elevated inflammatory markers such as TNF-α and bone-turnover regulators (PINP and TRACP-5b).[J Transl Med, 2025]

The proposed mechanism: inflammation and oxidative stress

Presence alone doesn’t damage a joint. The review’s argument is that microplastics trigger the same biological machinery already known to drive osteoarthritis.

According to the synthesis, the cascade begins with reactive oxygen species (ROS) overproduction, identified as the primary initiating event in microplastic toxicity across biological systems. At the cellular level, microplastics activate the NLRP3 inflammasome through TLR4/NF-κB signaling, increasing IL-1β secretion 4.3-fold in synovial macrophages. Polystyrene particles induced 2.8-fold higher mitochondrial superoxide production in chondrocytes.[J Transl Med, 2025]

The downstream effects reported are what make this relevant to joint degeneration:

• Collagen fragmentation rose 60% in articular cartilage exposed to polypropylene microplastics (10 µg/mL for 72 hours).[J Transl Med, 2025]
• Osteogenic differentiation was suppressed, with Runx2 expression down 42%, while osteoclast activity rose via RANKL upregulation.[J Transl Med, 2025]
• Chondrocyte apoptosis increased dose-dependently, reaching 35% cell death at 50 µg/mL.[J Transl Med, 2025]

The review also notes microplastic inclusions were found in 18% of synovial tissue samples taken from osteoarthritis patients undergoing joint replacement.[J Transl Med, 2025]

What the population data show

Mechanisms in a dish are one thing; patterns in people are another. The review pulls together epidemiological signals that point in the same direction.

A 10-year cohort in coastal Japan found fishing communities had 1.7 times higher age-adjusted osteoarthritis incidence (95% CI: 1.3–2.2) than inland populations, alongside elevated urinary microplastic metabolite levels. Industrial regions in China showed 23% greater knee osteoarthritis prevalence in areas with high atmospheric microplastic deposition.[J Transl Med, 2025]

1.85×

The review frames these as correlations consistent with the mechanistic story, not as proof that microplastics were the cause.

The honest caveat: association is not causation

This is where a credible reading of the paper diverges from the headline version.

Several of the studies synthesized are cell and animal experiments, and the epidemiological correlations—while controlled for age, BMI, and occupational factors—cannot rule out confounding entirely. The paper’s own conclusion describes microplastics as an “emerging” risk factor, language that signals a hypothesis under active investigation rather than a settled finding.

That candor is a feature, not a weakness. A review that overclaimed here would be less trustworthy, not more.

The economics of prevention

The review’s other argument is about money. Osteoarthritis is expensive—ranked as the fourth leading cause of global disability, with direct medical costs exceeding $460 billion annually and a total burden reaching roughly $0.51 trillion once lost productivity and informal care are included.[J Transl Med, 2025]

Against that backdrop, the authors model microplastic reduction as a cost-effective lever. Reducing dietary microplastic intake by 50% in coastal populations could, by their estimate, prevent 12% of osteoarthritis cases in those groups—approaching the roughly 14% prevention efficacy seen with weight-loss interventions—for potential global savings of about $55 billion per year.[J Transl Med, 2025]

Specific interventions they cost out include graphene oxide–based filtration membranes reported to remove up to 99.7% of microplastics from drinking water at roughly $0.12 per cubic meter treated, and seafood microplastic limits set at ≤ 0.01 mg/kg under 2023 EFSA guidelines that could cut exposure by up to 72% in fishing-dependent communities.[J Transl Med, 2025]

What to actually take from this

The defensible reading of this review is measured: microplastics have been found inside human joint tissue, they plausibly feed the inflammatory and oxidative processes that drive osteoarthritis, and populations with heavier exposure show higher osteoarthritis rates. What the evidence does not yet support is the flat statement that microplastics cause osteoarthritis in any individual.

For a reader, the practical implication is not panic but sensible exposure reduction—the same steps already justified by broader microplastic research: filtering drinking water and being mindful of high-accumulation food sources. The review itself points to filtration and dietary reduction as the most cost-effective mitigation strategies.[J Transl Med, 2025]

The larger takeaway is about how research like this should be read. A single translational synthesis raises a serious question and organizes the early evidence around it. It does not close the case. The authors are asking for longitudinal studies to do that—and until those exist, the appropriate posture is informed attention, not certainty.